Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial

M. K. Han, G. J. Criner, M. T. Dransfield, D. M. G. Halpin, C. E. Jones, S. Kilbride, P. Lange, D. A. Lipson, D. A. Lomas, F. J. Martinez, I. Naya, S. J. Pascoe, R. A. Wise, D. Singh

OriginalsprogEngelsk
ArtikelnummerA102
TidsskriftAmerican Journal of Respiratory and Critical Care Medicine
Vol/bind199
Udgave nummerA2438
ISSN1073-449X
DOI
StatusUdgivet - 2019

Citationsformater